USD 13.02
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 36.39 Million USD | 719.25% |
2022 | 4.44 Million USD | 104.37% |
2021 | -101.72 Million USD | -805.01% |
2020 | -11.24 Million USD | -163.9% |
2019 | 17.58 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 63.81 Million USD | 22.09% |
2024 Q1 | 52.26 Million USD | 43.62% |
2023 Q1 | -42.98 Million USD | -1067.78% |
2023 FY | 36.39 Million USD | 719.25% |
2023 Q4 | 36.39 Million USD | 356.08% |
2023 Q3 | 7.97 Million USD | 157.67% |
2023 Q2 | -13.83 Million USD | 67.82% |
2022 Q3 | -13.09 Million USD | 55.94% |
2022 FY | 4.44 Million USD | 104.37% |
2022 Q2 | -29.72 Million USD | 41.01% |
2022 Q1 | -50.39 Million USD | 50.46% |
2022 Q4 | 4.44 Million USD | 133.91% |
2021 Q2 | 6.25 Million USD | -64.28% |
2021 FY | -101.72 Million USD | -805.01% |
2021 Q1 | 17.5 Million USD | 255.7% |
2021 Q4 | -101.72 Million USD | -750.07% |
2021 Q3 | 15.64 Million USD | 150.29% |
2020 FY | -11.24 Million USD | -163.9% |
2020 Q1 | 2.61 Million USD | 0.0% |
2020 Q4 | -11.24 Million USD | 0.0% |
2019 FY | 17.58 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Abbott Laboratories | 8.97 Billion USD | 99.595% |
Allurion Technologies Inc. | 3.82 Million USD | -852.644% |
Artivion, Inc. | 300.4 Million USD | 87.886% |
Avanos Medical, Inc. | 121.4 Million USD | 70.024% |
Butterfly Network, Inc. | -109.6 Million USD | 133.201% |
Butterfly Network, Inc. | -109.6 Million USD | 133.201% |
Bio-Rad Laboratories, Inc. | 1 Billion USD | 96.368% |
Boston Scientific Corporation | 8.62 Billion USD | 99.578% |
CONMED Corporation | 966.95 Million USD | 96.237% |
Edwards Lifesciences Corporation | -449.1 Million USD | 108.103% |
Glaukos Corporation | 290.27 Million USD | 87.463% |
Globus Medical, Inc. | 53.11 Million USD | 31.483% |
Inspire Medical Systems, Inc. | -160.69 Million USD | 122.647% |
Integer Holdings Corporation | 1.01 Billion USD | 96.423% |
Medtronic plc | 24.76 Billion USD | 99.853% |
Myomo, Inc. | -6.27 Million USD | 680.398% |
Nevro Corp. | 117.61 Million USD | 69.058% |
Owlet, Inc. | -1.34 Million USD | 2813.723% |
Penumbra, Inc. | 66.85 Million USD | 45.569% |
Vicarious Surgical Inc. | -37.99 Million USD | 195.791% |
Smith & Nephew plc | 2.78 Billion USD | 98.692% |
Sonendo, Inc. | 26.34 Million USD | -38.148% |
STERIS plc | 3.17 Billion USD | 98.854% |
Stryker Corporation | 10.02 Billion USD | 99.637% |
Vapotherm, Inc. | 102.66 Million USD | 64.554% |
Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 99.348% |